Premium
P1–301: Modeling of clinical measures to predict florbetapir F18 PET results in mild and moderate Alzheimer's dementia
Author(s) -
Witte Michael,
Trzepacz Paula,
Case Michael,
Yu Peng,
Hochstetler Helen,
Walker Sara Kollack,
Sundell Karen,
Henley David
Publication year - 2013
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.05.527
Subject(s) - dementia , medicine , geriatric depression scale , logistic regression , alzheimer's disease , clinical dementia rating , clinical trial , psychology , disease , cognition , psychiatry , depressive symptoms
P1-301 MODELING OF CLINICAL MEASURES TO PREDICT FLORBETAPIR F18 PET RESULTS IN MILD AND MODERATE ALZHEIMER’S DEMENTIA Michael Witte, Paula Trzepacz, Michael Case, Peng Yu, Helen Hochstetler, Sara Kollack Walker, Karen Sundell, David Henley, Eli Lilly and Company, Indianapolis, Indiana, United States; Lilly Research Laboratories, Indianapolis, Indiana, United States. Contact e-mail: witte_michael_m@lilly.com